Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Bexlutry™

(lutetium Lu 177 dotatate injection)

Active ingredient

Lutetium Lu 177 dotatate

Disease area

Oncology

Available in

Erbium 169Er

Erbium (169Er) citrate 111 MBq/ml suspension for injection (ERMM-1)

Active ingredient

Er169-citrate

Disease area

Rheumatology

Available in
, 

Erbium 169Er in Czech Republic

Product information
, 

Erbium 169Er in France

Product information
, 

Erbium 169Er in Germany

Product information
, 

Erbium 169Er in International

Product information
, 

Erbium 169Er in South America

Product information

Erbium 169Er in Spain

Product information

Lutetium-177 chloride

Lutetium (¹⁷⁷Lu) chloride 40 GBq/mL radiopharmaceutical precursor

Active ingredient

Lutetium (¹⁷⁷Lu) chloride

Disease area

Oncology

Available in
, 

Lutetium-177 chloride in Austria

Product information
, 

Lutetium-177 chloride in Belgium

Product information
, 

Lutetium-177 chloride in France

Product information
, 

Lutetium-177 chloride in Germany

Product information
, 

Lutetium-177 chloride in Italy

Product information
, 

Lutetium-177 chloride in Netherlands

Product information
, 

Lutetium-177 chloride in Portugal

Product information
, 

Lutetium-177 chloride in Spain

Product information

Lutetium-177 chloride in Sweden

Product information

Quadramet®

Quadramet, 1.3 GBq/mL solution for injection

Active ingredient

Sm153-lexidronam

Disease area

Oncology

Available in
, 

Quadramet® in Austria

Product information
, 

Quadramet® in Belgium

Product information
, 

Quadramet® in Bulgaria

Product information
, 

Quadramet® in Croatia

Product information
, 

Quadramet® in Cyprus

Product information
, 

Quadramet® in Czech Republic

Product information
, 

Quadramet® in Denmark

Product information
, 

Quadramet® in Estonia

Product information
, 

Quadramet® in Finland

Product information
, 

Quadramet® in France

Product information
, 

Quadramet® in Germany

Product information
, 

Quadramet® in Greece

Product information
, 

Quadramet® in Hungary

Product information
, 

Quadramet® in Iceland

Product information
, 

Quadramet® in International

Product information
, 

Quadramet® in Ireland

Product information
, 

Quadramet® in Italy

Product information
, 

Quadramet® in Latvia

Product information
, 

Quadramet® in Lithuania

Product information
, 

Quadramet® in Luxembourg

Product information
, 

Quadramet® in Malta

Product information
, 

Quadramet® in Mexico

Product information
, 

Quadramet® in Netherlands

Product information
, 

Quadramet® in Norway

Product information
, 

Quadramet® in Poland

Product information
, 

Quadramet® in Portugal

Product information
, 

Quadramet® in Romania

Product information
, 

Quadramet® in Slovakia

Product information
, 

Quadramet® in Slovenia

Product information
, 

Quadramet® in Spain

Product information
, 

Quadramet® in Sweden

Product information

Quadramet® in United Kingdom

Product information

Rhenium 186Re

Rhenium (186Re) sulphide CIS bio international 148-370 MBq/mL suspension for intra-articular injection (Re-186-MM-1)

Active ingredient

Rhenium (186Re) sulphide colloid

Disease area

Rheumatology

Available in
, 

Rhenium 186Re in Czech Republic

Product information
, 

Rhenium 186Re in France

Product information
, 

Rhenium 186Re in Germany

Product information
, 

Rhenium 186Re in International

Product information
, 

Rhenium 186Re in South America

Product information

Rhenium 186Re in Spain

Product information

Sodium iodide (¹³¹I)

MONIYOT-131 Capsule T 37-7400 MBq hard capsule for therapeutic use

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) in Denmark

Product information
, 

Sodium iodide (¹³¹I) in Germany

Product information
, 

Sodium iodide (¹³¹I) in Greece

Product information

Sodium iodide (¹³¹I) in Romania

Product information

Sodium iodide (¹³¹I) – oral solution

MONIYOT-131 14.8–3700 MBq/mL oral solution

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) – oral solution in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Denmark

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Germany

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Greece

Product information

Sodium iodide (¹³¹I) – oral solution in Romania

Product information

Yttrium 90Y

Yttrium (90Y) citrate CIS bio international 150-370 MBq/mL suspension for intraarticular injection (YMM-1)

Active ingredient

Y90-citrate

Disease area

Rheumatology

Available in
, 

Yttrium 90Y in Belgium

Product information
, 

Yttrium 90Y in Czech Republic

Product information
, 

Yttrium 90Y in France

Product information
, 

Yttrium 90Y in Germany

Product information
, 

Yttrium 90Y in Hungary

Product information
, 

Yttrium 90Y in International

Product information
, 

Yttrium 90Y in Italy

Product information
, 

Yttrium 90Y in Luxembourg

Product information
, 

Yttrium 90Y in Netherlands

Product information
, 

Yttrium 90Y in Slovakia

Product information
, 

Yttrium 90Y in South America

Product information
, 

Yttrium 90Y in Spain

Product information

Yttrium 90Y in Switzerland

Product information